U.S. Beverage Stock News

NYSE:IP
NYSE:IPPackaging

International Paper (IP) Is Down 7.1% After Georgetown Closure And Regional Split Plan - What's Changed

International Paper has already decided to permanently close its Georgetown, South Carolina container plant by year-end 2026, after earlier shutting its local pulp and paper mill and selling its global cellulose fibers business, while also facing higher natural-gas costs from recent winter storms. At the same time, the company is preparing to split into two independent regional businesses, North America and EMEA, shifting away from global packaging deals toward a leaner, region-focused...
NasdaqGS:PYPL
NasdaqGS:PYPLDiversified Financial

Stripe Interest Puts PayPal Breakup Versus Turnaround Story In Focus

Stripe is reported to be exploring an early-stage acquisition of all or part of PayPal Holdings (NasdaqGS:PYPL). The interest comes as PayPal works through executive changes, including the appointment of Enrique Lores as CEO. At the same time, PayPal faces multiple shareholder lawsuits focused on business execution and financial disclosures. The combination of potential M&A, leadership turnover and legal scrutiny is drawing fresh attention to PayPal’s long term direction. For you as an...
NasdaqGM:PSNL
NasdaqGM:PSNLLife Sciences

Personalis (PSNL) Losses Of US$81.3 Million Keep Bearish Narratives In Focus

Personalis (PSNL) just posted its FY 2025 figures with Q4 revenue of about US$17.3 million and a basic EPS loss of roughly US$0.26, alongside a trailing twelve month EPS loss of about US$0.91 on revenue of roughly US$69.6 million. Over recent quarters, the company has seen quarterly revenue move between about US$14.5 million and US$20.6 million, while quarterly basic EPS losses have ranged from roughly US$0.18 to US$0.26. This keeps the focus squarely on when scale can start to ease those...
NasdaqGS:BIIB
NasdaqGS:BIIBBiotechs

Biogen’s BIIB080 Readout Tests Alzheimer’s Hopes And Investor Sentiment

Biogen is advancing its Alzheimer’s treatment pipeline, with mid year clinical results for its BIIB080 drug candidate expected in the coming months. The company is also progressing other neurology programs, including felzartamab and the early Alzheimer’s therapy Leqembi. Investors are watching these developments closely as the outcomes could influence sentiment on NasdaqGS:BIIB. Biogen, trading on NasdaqGS:BIIB, last closed at $191.8. The stock is up 9.7% over the past 30 days, 7.9% year to...
NYSE:VIA
NYSE:VIASoftware

Via Transportation (VIA) Q4 Loss Narrowing Tests Bearish Profitability Narrative

Via Transportation (VIA) FY 2025 earnings recap Via Transportation (VIA) just closed out FY 2025 with Q4 revenue of US$118.9 million and a basic EPS loss of US$0.28, while trailing twelve month revenue reached US$434.3 million against a full year EPS loss of US$1.21. The company has seen quarterly revenue move from US$83.3 million in Q3 2024 to US$118.9 million in Q4 2025, as basic EPS ranged between a loss of US$1.70 and US$0.28 over the same stretch, and over the last year management...
NYSE:BVN
NYSE:BVNMetals and Mining

Buenaventura Nears San Gabriel Completion As New Dividend Policy Takes Hold

Compañía de Minas Buenaventura (NYSE:BVN) reports its San Gabriel project is 99% complete, with commercial throughput targeted for 2026. The company has introduced a new dividend policy to pay out 40% of net income. BVN has affirmed a dividend alongside steady production performance and strong annual earnings. For you as an investor, this update combines a nearly finished growth project with a clear capital return framework. Compañía de Minas Buenaventura, a Peru-focused precious metals...
NasdaqGS:PBYI
NasdaqGS:PBYIBiotechs

Puma Biotechnology (PBYI) Margin Resilience Tests Bearish Earnings Forecasts In FY 2025 Results

Puma Biotechnology (PBYI) closed FY 2025 with Q4 revenue of US$75.5 million and basic EPS of US$0.27, alongside net income of US$13.4 million. Its trailing 12 month revenue came in at US$228.4 million with basic EPS of US$0.62 and net income of US$31.1 million. Over recent periods, the company has seen quarterly revenue range from US$46.0 million to US$80.5 million and basic EPS move between US$0.06 and US$0.98. This gives investors a clear view of how earnings scale with top line...
NYSE:EBS
NYSE:EBSBiotechs

Emergent BioSolutions (EBS) One Off Loss Clouds Return To Profitability Narrative

Emergent BioSolutions (EBS) has just wrapped up FY 2025 with Q4 revenue of US$148.7 million and basic EPS of a US$1.04 loss, capping a year in which quarterly revenue ranged from US$140.9 million to US$231.1 million and EPS swung between a profit of US$1.25 and a loss of US$0.22. Over the trailing 12 months to Q4 2025, the company recorded total revenue of US$742.9 million and basic EPS of US$0.98. This leaves investors to weigh improving headline profitability alongside still uneven...
NYSE:VFC
NYSE:VFCLuxury

A Look At V.F Corp (VFC) Valuation After J.P. Morgan Downgrade And Vans Brand Concerns

Recent analyst commentary on V.F (VFC) has focused on weakness at the Vans brand, with J.P. Morgan issuing a downgrade that questions how quickly the company can reach its stated operating margin goals. See our latest analysis for V.F. The latest analyst downgrade comes after a mixed year for investors, with a 10.97% 90 day share price return and a 6.94% year to date share price return, in contrast with a 20.33% 1 year total shareholder return decline. This suggests that recent momentum has...
NasdaqGS:PRAA
NasdaqGS:PRAAConsumer Finance

PRA Group (PRAA) Q4 Profit Of US$1.46 EPS Contrasts With Trailing Loss-Making Trend

PRA Group (PRAA) closed out FY 2025 with Q4 revenue of US$333.4 million and basic EPS of US$1.46, while the trailing 12 month picture shows total revenue of about US$1.2 billion and a basic EPS loss of US$7.79. The company has seen quarterly revenue move from US$293.2 million in Q4 2024 to US$333.4 million in Q4 2025, with basic EPS shifting from US$0.47 to US$1.46 over the same period, alongside a wider loss on a trailing 12 month basis of US$305.1 million. Margins look compressed on the...
NYSE:SWX
NYSE:SWXGas Utilities

Is Southwest Gas Holdings (SWX) Pricing Reflecting Recent Utility Sector Policy Focus?

If you are wondering whether Southwest Gas Holdings at around US$88 per share offers good value today, you are not alone; many investors are trying to work out what a fair price looks like. The stock has returned 0.7% over the last week, 7.6% over the past month, 10.0% year to date, 21.3% over one year, 62.5% over three years and 51.5% over five years, which naturally raises questions about how its current price lines up with its fundamentals. Recent news flow around regulated utilities, gas...
NYSE:UNFI
NYSE:UNFIConsumer Retailing

United Natural Foods Showcases Private Labels And Health Trends For Growth

United Natural Foods (NYSE:UNFI) hosted its 2026 Spring and Summer Selling Show, bringing together thousands of retailers and suppliers. The company unveiled nearly 50 new private label products across categories at the event. Key themes included healthier food offerings, private brand development, and growing interest in gut health. For you as an investor, this matters because UNFI sits at the center of the natural, specialty, and conventional grocery supply chain, connecting brands with...
NYSE:FCN
NYSE:FCNProfessional Services

FTI Consulting (FCN) Margin Decline To 7.1% Tests Bullish Earnings Leverage Narrative

FTI Consulting (FCN) has wrapped up FY 2025 with fourth quarter revenue of US$990.7 million and basic EPS of US$1.80, closing out a year where trailing twelve month revenue reached about US$3.8 billion and EPS came in at US$8.33. The company has seen revenue move from US$894.9 million in Q4 2024 to US$990.7 million in Q4 2025, while quarterly EPS shifted from US$1.41 to US$1.80. This may set the stage for investors to focus on how its 7.1% net margin and forecast earnings growth shape the...
NYSE:FNB
NYSE:FNBBanks

Is It Time To Reassess F.N.B (FNB) After Recent Regional Bank Sector Scrutiny?

If you are wondering whether F.N.B at around US$16.99 is still offering value, you are not alone. This article is built to help you make sense of where the stock stands on price versus fundamentals. The share price has seen mixed moves recently, with a 7 day return of 7.3% decline, a 30 day return of 1.4% decline, but a 1 year return of 18.1% and a 5 year return of 60.0%, which can change how investors think about both potential growth and risk. Recent coverage of regional banks and funding...
NYSE:HWM
NYSE:HWMAerospace & Defense

Howmet Debt Funded CAM Deal Highlights Growth Potential And Valuation Risk

Howmet Aerospace (NYSE:HWM) announced a plan to acquire Consolidated Aerospace Manufacturing (CAM). The company intends to fund the deal using proceeds from a mix of newly announced and completed debt offerings. The transaction is expected to influence Howmet's operations, market positioning, and capital structure once finalized. Howmet Aerospace, a key supplier of engineered components for aerospace and industrial markets, is moving to expand its footprint with the CAM acquisition. For you...
NYSE:DHI
NYSE:DHIConsumer Durables

The Bull Case For D.R. Horton (DHI) Could Change Following Cautious Housing-Demand Signals And Analyst Downgrades

Recently, D.R. Horton reiterated its full-year 2026 guidance but faced pressure as cautious housing-demand signals weighed on homebuilder sentiment. Analysts have turned more pessimistic on the company ahead of its April 21, 2026 earnings release, reflecting growing concern over sector headwinds. Next, we’ll examine how weakening housing-demand signals and more cautious analyst views may influence D.R. Horton’s existing investment narrative. The best AI stocks today may lie beyond giants...
NasdaqCM:SPT
NasdaqCM:SPTSoftware

Sprout Social (SPT) Q4 Loss Of US$0.18 Per Share Tests Profitability Narrative

Sprout Social (SPT) closed out FY 2025 with Q4 revenue of US$120.9 million and a basic EPS loss of US$0.18, while trailing twelve month figures show revenue of US$457.5 million and a basic EPS loss of US$0.73. Over recent quarters the company has seen revenue move from US$102.6 million in Q3 2024 to US$120.9 million in Q4 2025, with quarterly basic EPS losses ranging between US$0.16 and US$0.30, which keeps the focus firmly on how quickly the business can narrow those losses and improve...
NasdaqGM:KYMR
NasdaqGM:KYMRBiotechs

Kymera Therapeutics (KYMR) TTM Loss Of US$311 Million Tests Bullish Growth Narrative

Kymera Therapeutics (KYMR) closed FY 2025 with Q4 revenue of US$2.9 million and a basic EPS loss of US$0.97, while full year trailing twelve month figures showed revenue of US$39.2 million and a basic EPS loss of US$3.69. The company reported a decline in quarterly revenue from US$22.1 million in Q1 2025 to US$2.9 million in Q4, while basic EPS losses ranged between US$0.82 and US$0.97 across the year. This has set up a results season in which investors are weighing growth potential against...
NYSE:OMC
NYSE:OMCMedia

Omnicom Resets Priorities After Interpublic Deal With Buybacks And Cuts

Omnicom Group (NYSE:OMC) has approved major changes following its $13 billion acquisition of Interpublic Group. The company is planning coordinated layoffs and divestment of noncore and underperforming operations. Omnicom has also authorized a $5 billion share repurchase program as part of its updated capital plan. For investors watching Omnicom Group at a share price of $85.29, these moves come after a mix of recent returns, including 11.4% over the past 30 days and 36.4% over the past 5...
NYSE:SGI
NYSE:SGIConsumer Durables

Assessing Somnigroup International (SGI) Valuation After Q4 Miss And Ongoing Bedding Market Weakness

Somnigroup International (SGI) came under pressure after its fourth quarter results and a new dividend declaration, as revenue missed analyst expectations even though sales and earnings for the period were higher than a year earlier. See our latest analysis for Somnigroup International. The fourth quarter earnings and dividend announcement came after a period where the share price has cooled slightly, with a 1-day share price return showing a 1.76% decline and a 90-day share price return...
NYSE:XYL
NYSE:XYLMachinery

Xylem Approves US$1.5b Buyback As Shares Trade Below Estimates

Xylem (NYSE:XYL) has authorized a new share repurchase program of up to $1.5b. The program allows the company to buy back shares opportunistically over time. The announcement comes with Xylem shares recently trading around $129.56. Xylem, trading on the NYSE under the ticker XYL, is moving ahead with a sizeable $1.5b buyback plan at a share price of about $129.56. Over the past 3 years, the stock has returned 29.3%, and 37.1% over 5 years, which gives context for how management is choosing...
NYSE:UNP
NYSE:UNPTransportation

Twin Eagle Big Spring Expansion Adds Potential Tailwind For Union Pacific

Twin Eagle Terminals is expanding its Big Spring, Texas facility, which is served by Union Pacific (NYSE:UNP). The expanded terminal is expected to support greater throughput of a range of materials and strengthen local logistics infrastructure. This development directly affects Union Pacific’s freight operations by adding capacity within its network. For you as an investor following NYSE:UNP, this expansion highlights how the railroad supports freight flows in energy and industrial...
NYSE:HGTY
NYSE:HGTYInsurance

Hagerty (HGTY) Earnings Growth And 2.8% Margin Test Bullish Profit Narratives

Hagerty (HGTY) closed FY 2025 with Q4 revenue of US$357.3 million and basic EPS of US$0.07, alongside Q4 net income of US$6.9 million. On a trailing twelve month basis, revenue was US$1.5 billion, EPS was US$0.44 and net income was US$41.5 million. Over the last few quarters the company has seen revenue move from US$291.7 million and EPS of US$0.01 in Q4 FY 2024 to US$379.9 million and EPS of US$0.18 in Q3 FY 2025, before landing at the latest Q4 figures. This sets up a story where higher...
NYSE:APH
NYSE:APHElectronic

Amphenol Deepens AI Data Center Role With CCS Deal And Defense Growth

Amphenol (NYSE:APH) reports record sales and a strong backlog tied to demand across AI semiconductor and data center markets. The company expands its position in AI infrastructure and defense interconnects, with increasing focus on data center and military programs. Amphenol closes the acquisition of CommScope's CCS business, broadening its connectivity portfolio across broadband and data networks. Amphenol, a major supplier of interconnect and sensing solutions, is increasingly tied to AI...